MicroRNA-20a suppresses tumor proliferation and metastasis in hepatocellular carcinoma by directly targeting EZH1.

Hepatocellular carcinoma (HCC), a worldwide leading cause of morbidity and mortality, is the most frequent primary liver tumor. Most HCC patients are diagnosed with advanced liver cancer, resulting in a very low 5-year survival rate.

肝细胞癌（Hepatocellular carcinoma, HCC）是全球范围内导致发病与死亡的首要病因，亦是最为常见的原发性肝脏肿瘤。多数肝细胞癌患者在确诊时已处于肝癌晚期，致使其5年生存率极低。